News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s Parkinson's Disease and Movement Disorders Center. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.

  • PDMDC Seminar Featuring Anne J. Blood, PhD, Tuesday, December 2
    11.18.2014

    The Parkinson’s Disease and Movement Disorders Center seminar featuring Anne J. Blood, PhD. She is the director of the Mood and Motor Control Laboratory Departments of Psychiatry and Neurology Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital. She will present,"Brain Imaging as a Hypothesis Generating Tool: Implications for Studying Pathophysiology and Biomarkers in Movement Disorders".

    Tuesday, December 2, 2014, 3:30-4:30 PM, Robert H. Lurie Medical Research Center, 303 E. Superior Street, Baldwin Auditorium.

    Dr. Blood's current research interests include developing a model for motor control that can be mapped down to the neural level, model- and data-driven biological subtyping of mood and motor disorders with translational relevance, mathematical modeling of human preference behavior and its relevance to addiction and mood disorders, and investigating the neural basis for comorbidity of mood and motor disorders.

  • 11.11.2014
  • 2014 Cures Within Reach Research Patient Impact Award
    06.18.2014

    Drs. Tanya Simuni and Jim Surmeier were selected to receive the 2014 Cures Within Reach Research Patient Impact Award, which was presented, at the Bioscience Awards of the Midwest event on June 17, 2014.  Congratulations!

  • 05.03.2014
    Center study featured in the Chicago Sun Times for May 3, 2014.
  • 04.02.2014
    Tanya Simuni, MD, medical director of Northwestern University’s Parkinson’s Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health (NIH) to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
  • Long-term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy
    02.12.2014
  • 01.31.2014

    Recognized for its approach to uncovering new therapeutic targets in the fight against Parkinson’s disease (PD), Northwestern University Feinberg School of Medicine will continue that pursuit as a National Institutes of Health Center of Excellence. The only medical school to receive new or renewed designation as a Morris K. Udall Center of Excellence for Parkinson’s Disease Research in 2013, Feinberg became the Midwest’s first site in 2003, and today is one of just 10 nationwide.